Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 43.59 Billion JPY | -75.66% |
| 2023 | 179.12 Billion JPY | 19.93% |
| 2022 | 149.35 Billion JPY | 42.47% |
| 2021 | 104.83 Billion JPY | 3.18% |
| 2020 | 101.6 Billion JPY | 40.78% |
| 2019 | 72.17 Billion JPY | -14.37% |
| 2018 | 84.28 Billion JPY | 4.32% |
| 2017 | 80.78 Billion JPY | -22.66% |
| 2016 | 104.46 Billion JPY | 14.84% |
| 2015 | 90.96 Billion JPY | 23.85% |
| 2014 | 73.44 Billion JPY | 109.38% |
| 2013 | 35.07 Billion JPY | -1.24% |
| 2012 | 35.51 Billion JPY | -7.45% |
| 2011 | 38.37 Billion JPY | -36.19% |
| 2010 | 60.14 Billion JPY | 73.91% |
| 2009 | 34.58 Billion JPY | -69.29% |
| 2008 | 112.62 Billion JPY | 14.07% |
| 2007 | 98.72 Billion JPY | 57.91% |
| 2006 | 62.52 Billion JPY | 170.04% |
| 2005 | 23.15 Billion JPY | -63.25% |
| 2004 | 62.99 Billion JPY | 1.04% |
| 2003 | 62.34 Billion JPY | 47.45% |
| 2002 | 42.28 Billion JPY | 19.12% |
| 2001 | 35.49 Billion JPY | -91.72% |
| 2000 | 428.64 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 149.75 Billion JPY | -16.4% |
| 2024 Q1 | 28.45 Billion JPY | -41.52% |
| 2024 Q3 | 43.72 Billion JPY | 14.01% |
| 2024 Q2 | 38.34 Billion JPY | 34.76% |
| 2024 Q4 | 41.36 Billion JPY | -5.39% |
| 2023 Q2 | 49.28 Billion JPY | 74.2% |
| 2023 Q1 | 28.29 Billion JPY | -41.15% |
| 2023 FY | 179.12 Billion JPY | 19.93% |
| 2023 Q4 | 48.66 Billion JPY | 0.03% |
| 2023 Q3 | 48.64 Billion JPY | -1.3% |
| 2022 Q1 | 27.68 Billion JPY | -5.34% |
| 2022 Q3 | 39.42 Billion JPY | -23.13% |
| 2022 Q4 | 48.07 Billion JPY | 21.96% |
| 2022 FY | 149.35 Billion JPY | 42.47% |
| 2022 Q2 | 51.28 Billion JPY | 85.21% |
| 2021 Q2 | 26.58 Billion JPY | 616.72% |
| 2021 Q1 | 3.7 Billion JPY | -25.58% |
| 2021 Q4 | 29.25 Billion JPY | -15.07% |
| 2021 FY | 104.83 Billion JPY | 3.18% |
| 2021 Q3 | 34.44 Billion JPY | 29.56% |
| 2020 Q2 | 39.26 Billion JPY | 166.42% |
| 2020 FY | 101.6 Billion JPY | 40.78% |
| 2020 Q3 | 28.86 Billion JPY | -26.48% |
| 2020 Q4 | 4.98 Billion JPY | -82.73% |
| 2020 Q1 | 14.73 Billion JPY | 91.45% |
| 2019 Q2 | 14.62 Billion JPY | 225.65% |
| 2019 Q1 | -11.63 Billion JPY | -154.85% |
| 2019 Q4 | 7.69 Billion JPY | -56.26% |
| 2019 FY | 72.17 Billion JPY | -14.37% |
| 2019 Q3 | 17.59 Billion JPY | 20.34% |
| 2018 Q3 | 22.41 Billion JPY | -9.2% |
| 2018 FY | 84.28 Billion JPY | 4.32% |
| 2018 Q1 | 12.7 Billion JPY | -41.57% |
| 2018 Q4 | 21.22 Billion JPY | -5.33% |
| 2018 Q2 | 24.68 Billion JPY | 94.27% |
| 2017 Q3 | 20.54 Billion JPY | -6.86% |
| 2017 Q2 | 22.05 Billion JPY | 65.06% |
| 2017 FY | 80.78 Billion JPY | -22.66% |
| 2017 Q1 | 13.36 Billion JPY | -56.6% |
| 2017 Q4 | 21.74 Billion JPY | 5.86% |
| 2016 FY | 104.46 Billion JPY | 14.84% |
| 2016 Q2 | 32.91 Billion JPY | 91.76% |
| 2016 Q1 | 17.16 Billion JPY | -40.59% |
| 2016 Q4 | 30.79 Billion JPY | 30.51% |
| 2016 Q3 | 23.59 Billion JPY | -28.32% |
| 2015 FY | 90.96 Billion JPY | 23.85% |
| 2015 Q2 | 23.37 Billion JPY | 55.27% |
| 2015 Q3 | 23.64 Billion JPY | 1.15% |
| 2015 Q1 | 15.05 Billion JPY | -36.08% |
| 2015 Q4 | 28.89 Billion JPY | 22.21% |
| 2014 Q2 | 20.33 Billion JPY | 149.04% |
| 2014 Q3 | 21.39 Billion JPY | 5.19% |
| 2014 Q4 | 23.54 Billion JPY | 10.08% |
| 2014 FY | 73.44 Billion JPY | 109.38% |
| 2014 Q1 | 8.16 Billion JPY | -21.98% |
| 2013 Q2 | 15.92 Billion JPY | 651.75% |
| 2013 Q4 | 10.46 Billion JPY | 59.32% |
| 2013 Q3 | 6.57 Billion JPY | -58.74% |
| 2013 Q1 | 2.11 Billion JPY | -77.84% |
| 2013 FY | 35.07 Billion JPY | -1.24% |
| 2012 Q2 | 13.07 Billion JPY | 149.3% |
| 2012 Q1 | 5.24 Billion JPY | -6.48% |
| 2012 Q3 | 8.42 Billion JPY | -35.55% |
| 2012 Q4 | 9.55 Billion JPY | 13.47% |
| 2012 FY | 35.51 Billion JPY | -7.45% |
| 2011 Q1 | 11.15 Billion JPY | -26.15% |
| 2011 Q2 | 9.67 Billion JPY | -13.24% |
| 2011 FY | 38.37 Billion JPY | -36.19% |
| 2011 Q4 | 5.6 Billion JPY | -37.17% |
| 2011 Q3 | 8.92 Billion JPY | -7.79% |
| 2010 Q1 | 11.36 Billion JPY | 144.72% |
| 2010 FY | 60.14 Billion JPY | 73.91% |
| 2010 Q3 | 16.52 Billion JPY | -3.67% |
| 2010 Q4 | 15.1 Billion JPY | -8.62% |
| 2010 Q2 | 17.15 Billion JPY | 51.04% |
| 2009 FY | 34.58 Billion JPY | -69.29% |
| 2009 Q4 | 4.64 Billion JPY | 315.51% |
| 2009 Q3 | -2.15 Billion JPY | -114.8% |
| 2009 Q2 | 14.55 Billion JPY | -17.03% |
| 2009 Q1 | 17.54 Billion JPY | 0.0% |
| 2008 FY | 112.62 Billion JPY | 14.07% |
| 2007 FY | 98.72 Billion JPY | 57.91% |
| 2006 FY | 62.52 Billion JPY | 170.04% |
| 2005 FY | 23.15 Billion JPY | -63.25% |
| 2004 FY | 62.99 Billion JPY | 1.04% |
| 2003 FY | 62.34 Billion JPY | 47.45% |
| 2002 FY | 42.28 Billion JPY | 19.12% |
| 2001 FY | 35.49 Billion JPY | -91.72% |
| 2000 FY | 428.64 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -3744724.861% |
| Ansell Limited | 129.3 Million USD | -33618.484% |
| Ansell Limited | 129.3 Million USD | -33618.484% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -139914.561% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 2732316.123% |
| Psykey, Inc. | -797.5 Thousand USD | 5466906.436% |
| ConvaTec Group Plc | 262.7 Million USD | -16496.117% |
| ConvaTec Group Plc | 262.7 Million USD | -16496.117% |
| Encision Inc. | -640.78 Thousand USD | 6803963.398% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 30744053.177% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 39659883.499% |
| Innovative MedTech Inc. | -4.27 Million USD | 1020156.733% |
| LifePoint, Inc. | -7.49 Million USD | 581776.768% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 672908.642% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -13211415.152% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 35477356.083% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 9330306.002% |
| SmileDirectClub, Inc. | -241.15 Million USD | 18178.754% |
| Sector 10, Inc. | -39.84 Thousand USD | 109421844.805% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -13541.137% |
| SheerVision, Inc. | 155.72 Thousand USD | -27996509.429% |
| United Health Products, Inc. | -2.42 Million USD | 1796815.404% |
| Vasamed, Inc. | 4.74 Million USD | -919242.547% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 1900506.296% |
| Yubo International Biotech Limited | -1.2 Million USD | 3617521.838% |